Neutrophil to lymphocyte ratio (NLR) as an indicator of poor prognosis in stage IV non-small cell lung cancer
Top Cited Papers
- 19 July 2012
- journal article
- research article
- Published by Springer Science and Business Media LLC in Clinical and Translational Oncology
- Vol. 14 (11), 864-869
- https://doi.org/10.1007/s12094-012-0872-5
Abstract
Neutrophil to lymphocyte ratio (NLR), an index of systemic inflammation, has been associated with worse survival for many types of cancer. The aim of this study is to investigate the clinical significance of the blood NLR as a prognostic factor in non-small cell lung cancer (NSCLC) patients.Keywords
This publication has 20 references indexed in Scilit:
- High Blood Neutrophil-to-Lymphocyte Ratio Is an Indicator of Poor Prognosis in Malignant Mesothelioma Patients Undergoing Systemic TherapyClinical Cancer Research, 2010
- Pretreatment neutrophil count as an independent prognostic factor in advanced non-small-cell lung cancer: An analysis of Japan Multinational Trial Organisation LC00-03European Journal of Cancer, 2009
- Systemic inflammation, nutritional status and survival in patients with cancerCurrent Opinion in Clinical Nutrition and Metabolic Care, 2009
- Cancer-related inflammationNature, 2008
- Impact of systemic inflammation on outcome following resection for intrahepatic cholangiocarcinomaJournal of Surgical Oncology, 2008
- Elevated preoperative neutrophil to lymphocyte ratio predicts survival following hepatic resection for colorectal liver metastasesEuropean Journal of Surgical Oncology, 2008
- Comparison of the prognostic value of selected markers of the systemic inflammatory response in patients with colorectal cancerBritish Journal of Cancer, 2007
- The IASLC Lung Cancer Staging Project: Validation of the Proposals for Revision of the T, N, and M Descriptors and Consequent Stage Groupings in the Forthcoming (Seventh) Edition of the TNM Classification of Malignant TumoursJournal of Thoracic Oncology, 2007
- Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancerJournal of Surgical Oncology, 2005
- Clinical Model to Predict Survival in Chemonaive Patients With Advanced Non–Small-Cell Lung Cancer Treated With Third-Generation Chemotherapy Regimens Based on Eastern Cooperative Oncology Group DataJournal of Clinical Oncology, 2005